The lecture will introduce the key activities and technologies at CERN-MEDICIS, a unique facility dedicated to producing high-purity radionuclides for medical research and applications. These radionuclides are essential for next-generation diagnostics and therapies in nuclear medicine, especially when conventional production methods cannot supply them.

The session will explain how radionuclides are produced at CERN-MEDICIS – starting from the irradiation of special target materials, followed by collection and purification. A major focus will be on the mass separation process, which uses electromagnetic fields to isolate specific isotopes with very high purity, removing unwanted radioactive by-products that could interfere with medical use.

The lecture will also highlight recent progress in developing new target materials that can withstand high radiation and heat while maximizing isotope production. This includes work with advanced materials such as nanostructured and refractory compounds.

By combining expertise in nuclear physics, radiochemistry, materials science and medicine, CERN-MEDICIS plays a key role in advancing nuclear medicine and supporting the development of personalized treatment strategies.

Tea and cookies are offered 30 minutes before the seminar.